https://t.co/Z587MjE3mT “While preclinical models have been less than ideal in predicting the outcome of gene transfer in humans, the current preclinical body of evidence clearly demonstrates that rAAV vectors can trigger both innate and adaptive immune responses.”
Human Immune Responses to Adeno-Associated Virus (AAV) Vectors.
Mentions
Extended reach
Total likes
Video views
Mentions per month
May 2020 – May 2023Where it's discussed
-
News10 articles
-
X / Twitter7 posts
-
Blogs3 articles
-
YouTube2 videos
AI synopsis
What people are saying
The discussions reflect a balanced recognition of the article's importance, with statements like 'rAAV vectors can trigger both innate and adaptive immune responses,' showing the relevance of immune responses in gene transfer. The tone is analytical and emphasizes the challenges in translating preclinical models to humans, underscoring the impact of the research on future therapies.
Most discussions acknowledge that preclinical models don't fully predict human immune responses, showing a moderate consensus on the article's findings.
Participants express a moderate level of curiosity about how immune responses affect gene therapy, indicating engagement but not overwhelming enthusiasm.
The posts reference specific aspects like innate and adaptive immunity and mention the research by Ronzitti et al., demonstrating a basic but meaningful level of engagement.
The discussions highlight that understanding immune responses is crucial for advancing gene therapy, suggesting a recognition of their significance.
Abstract in brief
- Recombinant adeno-associated virus (rAAV) vectors are promising tools for gene delivery due to their efficiency, but their high similarity to wildtype viruses that infect humans can lead to immune responses that limit their effectiveness.
- Both humoral (antibody-mediated) and cell-mediated immune responses to wildtype AAV are observed in healthy donors, and anti-AAV antibodies can significantly affect gene transfer outcomes.
- Factors like vector design and dosage influence the immune response, with current research indicating that rAAV vectors can trigger both innate and adaptive immunity, presenting challenges and opportunities for improving gene therapy strategies.]
Top posts
Most liked on X and BlueskyHuman Immune Responses to Adeno-Associated Virus (AAV) Vectors https://t.co/IVh5dNGFCv
RT @CartlandDavid: https://t.co/Z587MjE3mT “While preclinical models have been less than ideal in predicting the outcome of gene transfer i…
RT @CartlandDavid: https://t.co/Z587MjE3mT “While preclinical models have been less than ideal in predicting the outcome of gene transfer i…
RT @CartlandDavid: https://t.co/Z587MjE3mT “While preclinical models have been less than ideal in predicting the outcome of gene transfer i…
Trend new: *Ronzitti G* et al (Front Immunol) __Human Immune Responses to Adeno-Associated Virus (AAV) Vectors__ https://t.co/FhUojmC2cE
All mentions
Immune Response Challenges in AAV-Based Gene Therapy
Recombinant adeno-associated virus vectors are effective for gene delivery but can provoke immune responses that limit their success. These responses include both humoral and cell-mediated immunity, influenced by vector…
Adeno-Associated Virus and CRISPR-Cas9 in Gene Therapy
Recombinant adeno-associated virus vectors are promising tools for gene delivery, but their similarity to wildtype viruses can trigger immune responses. These responses may affect gene therapy effectiveness, influenced…
RT @CartlandDavid: https://t.co/Z587MjE3mT “While preclinical models have been less than ideal in predicting the outcome of gene transfer i…
RT @CartlandDavid: https://t.co/Z587MjE3mT “While preclinical models have been less than ideal in predicting the outcome of gene transfer i…
RT @CartlandDavid: https://t.co/Z587MjE3mT “While preclinical models have been less than ideal in predicting the outcome of gene transfer i…
RT @CartlandDavid: https://t.co/Z587MjE3mT “While preclinical models have been less than ideal in predicting the outcome of gene transfer i…
https://t.co/Z587MjE3mT “While preclinical models have been less than ideal in predicting the outcome of gene transfer in humans, the current preclinical body of evidence clearly demonstrates that rAAV vectors can trigger both innate and adaptive immune responses.”
Trend new: *Ronzitti G* et al (Front Immunol) __Human Immune Responses to Adeno-Associated Virus (AAV) Vectors__ https://t.co/FhUojmC2cE
Human Immune Responses to Adeno-Associated Virus (AAV) Vectors https://t.co/IVh5dNGFCv
DM
F
MS
ET
E
TL
W